Respiratory syncytial virus (RSV) is a common airway pathogen that can cause severe illness, yet there is no vaccine or effective therapy available. Tayyari et al. now report that nucleolin is a cellular receptor for RSV and suggest that nucleolin-targeting strategies could be developed to inhibit RSV infection and protect against disease.
- Farnoosh Tayyari
- David Marchant
- Richard G Hegele
